A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.

NCT00558298 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

811

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: risperidone

Sponsor

Janssen, LP